Market Overview:
The global intramuscular drug delivery equipment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in intramuscular drug delivery equipment. Based on type, the global intramuscular drug delivery equipment market is segmented into molecular structures intramuscular drug delivery equipment, polymers intramuscular drug delivery equipment, gels intramuscular drug delivery equipment, and others. The molecular structures segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of 8% during the forecast period from 2018 to 2030. This growth can be attributed to technological advancements in this segment that have led to increased efficiency and accuracy in delivering drugs into muscles.
Product Definition:
Intramuscular Drug Delivery Equipment is a device used to inject medication into the muscle tissue. The importance of Intramuscular Drug Delivery Equipment is that it allows for the delivery of medication directly to the muscles, which can help to improve absorption and efficacy.
Molecular Structures Intramuscular Drug Delivery Equipment:
The global molecular structures intramuscular drug delivery equipment, it's usage and growth factor in the market are expected to grow at a significant rate over the forecast period. The factors that propel their demand include increasing incidences of diseases such as diabetes, arthritis and other autoimmune disorders coupled with rising geriatric population base across the globe. Moreover, growing awareness levels amongst patients regarding self-medication is also one of the key factors responsible for this surge in demand.
Polymers Intramuscular Drug Delivery Equipment:
Polymers intramuscular drug delivery equipment are used in the process of intramuscular drug delivery. Intramuscular drug delivery is a mode of delivering drugs that involves injecting them directly into muscle tissues. The most commonly used polymers for this purpose are hydrogels, microparticles, and nanoparticles among others.
Application Insights:
On the basis of application, the global intramuscular drug delivery equipment market is segmented into infectious diseases, oncology, autoimmune diseases and others. The infectious disease segment held a major share in 2017 owing to increasing prevalence of HIV/AIDS and tuberculosis. According to UNAIDS Report 2016: AIDS Epidemic update 1 December 2016 - 19 November 2017, over 34 million people were living with HIV across the globe. Moreover, according to WHO Global Report on Trends in Maternal & Child Health 2018; over TB was diagnosed in nearly 9 million individuals worldwide and around 2.5 million died due to TB during 2015 - 2016. Thus rising incidences of these two diseases are expected to boost demand for intramuscular drug delivery systems during forecast period (2018-2030).
The cancer treatment segment is anticipated register significant growth during forecast period owing to increasing incidence rate of cancer across the globe coupled with growing awareness about available treatment options such as chemotherapy.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D, and increasing prevalence of target diseases. The U.S., which is at the forefront, accounts for most cases owing to its advanced healthcare system and favorable government policies supporting drug development activities.
Asia Pacific is expected to register lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure coupled with rising disposable income leading towards better treatment options for patients suffering from various chronic diseases including cancer & diabetes that require intramuscular drug delivery systems for effective medication administration course thus positively impacting overall market growth over next eight years.
Growth Factors:
- Increasing demand for novel and targeted drug delivery methods
- Growing prevalence of chronic diseases that require long-term treatment
- Rising number of clinical trials for new intramuscular drugs
- Technological advancements in intramuscular drug delivery equipment
- Growing focus on patient convenience and comfort
Scope Of The Report
Report Attributes
Report Details
Report Title
Intramuscular Drug Delivery Equipment Market Research Report
By Type
Molecular Structures Intramuscular Drug Delivery Equipment, Polymers Intramuscular Drug Delivery Equipment, Gels Intramuscular Drug Delivery Equipment, Others
By Application
Infectious Disease, Oncology, Autoimmune Diseases
By Companies
Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, Inovio Pharmaceuticals, Merck, Novartis, Pacira Pharmaceuticals, Pfizer, Pharmajet, Teva Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Intramuscular Drug Delivery Equipment Market Report Segments:
The global Intramuscular Drug Delivery Equipment market is segmented on the basis of:
Types
Molecular Structures Intramuscular Drug Delivery Equipment, Polymers Intramuscular Drug Delivery Equipment, Gels Intramuscular Drug Delivery Equipment, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infectious Disease, Oncology, Autoimmune Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Antares Pharma
- Eli Lily
- Galaxo
- HMD pharmaceuticals
- Inovio Pharmaceuticals
- Merck
- Novartis
- Pacira Pharmaceuticals
- Pfizer
- Pharmajet
- Teva Pharmaceutical
Highlights of The Intramuscular Drug Delivery Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Molecular Structures Intramuscular Drug Delivery Equipment
- Polymers Intramuscular Drug Delivery Equipment
- Gels Intramuscular Drug Delivery Equipment
- Others
- By Application:
- Infectious Disease
- Oncology
- Autoimmune Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intramuscular Drug Delivery Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intramuscular drug delivery equipment is a medical device that helps inject drugs into the muscle. It can be used to deliver medications directly to the site of injury or disease, or to provide continuous treatment over an extended period of time.
Some of the major players in the intramuscular drug delivery equipment market are Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, Inovio Pharmaceuticals, Merck, Novartis, Pacira Pharmaceuticals, Pfizer, Pharmajet, Teva Pharmaceutical.
The intramuscular drug delivery equipment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intramuscular Drug Delivery Equipment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intramuscular Drug Delivery Equipment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intramuscular Drug Delivery Equipment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intramuscular Drug Delivery Equipment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intramuscular Drug Delivery Equipment Market Size & Forecast, 2020-2028
4.5.1 Intramuscular Drug Delivery Equipment Market Size and Y-o-Y Growth
4.5.2 Intramuscular Drug Delivery Equipment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Molecular Structures Intramuscular Drug Delivery Equipment
5.2.2 Polymers Intramuscular Drug Delivery Equipment
5.2.3 Gels Intramuscular Drug Delivery Equipment
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Infectious Disease
6.2.2 Oncology
6.2.3 Autoimmune Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intramuscular Drug Delivery Equipment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intramuscular Drug Delivery Equipment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Molecular Structures Intramuscular Drug Delivery Equipment
9.6.2 Polymers Intramuscular Drug Delivery Equipment
9.6.3 Gels Intramuscular Drug Delivery Equipment
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Infectious Disease
9.10.2 Oncology
9.10.3 Autoimmune Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Molecular Structures Intramuscular Drug Delivery Equipment
10.6.2 Polymers Intramuscular Drug Delivery Equipment
10.6.3 Gels Intramuscular Drug Delivery Equipment
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Infectious Disease
10.10.2 Oncology
10.10.3 Autoimmune Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Molecular Structures Intramuscular Drug Delivery Equipment
11.6.2 Polymers Intramuscular Drug Delivery Equipment
11.6.3 Gels Intramuscular Drug Delivery Equipment
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Infectious Disease
11.10.2 Oncology
11.10.3 Autoimmune Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Molecular Structures Intramuscular Drug Delivery Equipment
12.6.2 Polymers Intramuscular Drug Delivery Equipment
12.6.3 Gels Intramuscular Drug Delivery Equipment
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Infectious Disease
12.10.2 Oncology
12.10.3 Autoimmune Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Molecular Structures Intramuscular Drug Delivery Equipment
13.6.2 Polymers Intramuscular Drug Delivery Equipment
13.6.3 Gels Intramuscular Drug Delivery Equipment
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Infectious Disease
13.10.2 Oncology
13.10.3 Autoimmune Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intramuscular Drug Delivery Equipment Market: Competitive Dashboard
14.2 Global Intramuscular Drug Delivery Equipment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Antares Pharma
14.3.2 Eli Lily
14.3.3 Galaxo
14.3.4 HMD pharmaceuticals
14.3.5 Inovio Pharmaceuticals
14.3.6 Merck
14.3.7 Novartis
14.3.8 Pacira Pharmaceuticals
14.3.9 Pfizer
14.3.10 Pharmajet
14.3.11 Teva Pharmaceutical
